NCT03674073 — Chinese PLA General Hospital neoantigen vaccine trial
A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma
Registry record
| Registry ID | NCT03674073 ↗ |
|---|---|
| Lead sponsor | Chinese PLA General Hospital |
| Collaborators | Likang Life Sciences Holdings Limited |
| Phase | Phase 1 |
| Status | Completed |
| Indication | Hepatocellular Carcinoma, Liver Cancer, Adult |
| Enrollment | 24 participants |
| Start date | 2018-10-15 |
| Primary completion | 2020-10-15 |
| Last registry update | 27 Aug 2026 |
Every field above is mirrored from the study record on ClinicalTrials.gov (NCT03674073), which the sponsor maintains and which carries the full protocol summary, eligibility criteria, sites and contacts. No neoantigen vaccine is approved anywhere yet — every program here is investigational, and inclusion is not an endorsement. See the methodology for how the tracker is built.
Where this fits
Daily coverage of the modality, tumor type and players this study touches:
Related trials
FAQ
What phase is NCT03674073?
NCT03674073 (A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma) is registered on ClinicalTrials.gov as Phase 1, sponsored by Chinese PLA General Hospital.
Is NCT03674073 recruiting?
As of the 2026-08-27 registry update, NCT03674073 is listed as "Completed". Eligibility criteria, study sites and contacts are maintained by the sponsor on the ClinicalTrials.gov record.
Who is running NCT03674073?
The lead sponsor is Chinese PLA General Hospital. Collaborators: Likang Life Sciences Holdings Limited.
What condition does NCT03674073 study?
The registered conditions are Hepatocellular Carcinoma, Liver Cancer, Adult. Primary completion is listed as 2020-10-15.
Are results available for NCT03674073?
neoag.ai mirrors the registry's factual fields — sponsor, phase, status and dates — and does not publish trial results. Any posted results, publications, or outcome measures appear on the ClinicalTrials.gov record for NCT03674073.
Back to the full neoantigen vaccine trial tracker — 107 studies, refreshed daily from ClinicalTrials.gov. Background: primer, glossary, and the companies landscape.